US › Healthcare

Electrocore LLC (ECOR)

US · Healthcare · Medical Devices

$11.38+6.85%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9.4M

Revenue YoY

+28.0%

Net profit

$-3.1M

EPS

$-0.33

EPS estimate

$-0.41

Net margin

-32.4%

EPS came in at -0.33 against a street estimate of -0.41 — a beat of 19.5%.

Key statistics

Market cap

$86.7M

Forward P/E

384.6

P/B

34.89

Book value

$-0.31

EPS (TTM)

$-1.65

52-week high

$10.95

52-week low

$4.41

50-day MA

$8.05

200-day MA

$6.95

Beta

1.01

Analyst view

Analysts rate Electrocore LLC a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $19.17.

Shareholding

Insiders

32.45%

Institutions

11.64%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.25%
Balyasny Asset Management LLC	1.29%
FourWorld Capital Management LLC	1.04%
Wexford Capital LP	1.02%
Geode Capital Management, LLC	0.87%
JAFFETILCHIN INVESTMENT PARTNERS, LLC	0.65%
Sontag Advisory LLC	0.53%
Renaissance Technologies Corp	0.49%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Electrocore LLC — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.